2015-2025 Global Flu Vaccine Market Research by Type, End-Use and Region (COVID-19 Version)
- 99S4000656
- 147 Pages
- August 2020
- Healthcare
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Flu Vaccine market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
.
Market Segment as follows:
Key Companies
AstraZeneca
CSL Limited
GSK
Hualun Biologicalsamong
ID Biomedical Corporation
Johnson & Johnson
MedImmune, LLC
Mylan
Novartis
Pfizer
Protein Sciences Corporaton
Sanofi Pasteur
Serum Institute of India
Sinovac Biotech
Key Types
Fluzone/Vaxigrip
Anflu
FluMist
Fluarix
FluLaval
Fluvax/Afluria
Fluvirin
Others
Market by Influenza Viruses
Influenza A viruses
Influenza B viruses
Others
Key End-Use
Pediatrics
Adults
This report can be dispatched within 24-48 Hours.
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Flu Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Flu Vaccine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Flu Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Flu Vaccine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Flu Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaFlu Vaccine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Flu Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Flu Vaccine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Flu Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Flu Vaccine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Figure Global Flu Vaccine Consumption Value (Million USD) and Growth Rate List, 2015-2020
2.3 Global Production by Type
Table Global Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Global Flu Vaccine Revenue Share by Type in 2020 (Million USD)
2.4 Global Consumption by End-Use
Table Global Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Flu Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
2.5 Global Consumption by Region
Table Global Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Figure Europe Flu Vaccine Consumption Value (Million USD) and Growth Rate List, 2015-2020
3.3 Europe Production by Type
Table Europe Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Europe Flu Vaccine Revenue Share by Type in 2020 (Million USD)
3.4 Europe Consumption by End-Use
Table Europe Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Flu Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
3.5 Europe Consumption by Region
Table Europe Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Figure America Flu Vaccine Consumption Value (Million USD) and Growth Rate List, 2015-2020
4.3 America Production by Type
Table America Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure America Flu Vaccine Revenue Share by Type in 2020 (Million USD)
4.4 America Consumption by End-Use
Table America Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Flu Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
4.5 America Consumption by Region
Table America Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Figure Asia Flu Vaccine Consumption Value (Million USD) and Growth Rate List, 2015-2020
5.3 Asia Production by Type
Table Asia Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Asia Flu Vaccine Revenue Share by Type in 2020 (Million USD)
5.4 Asia Consumption by End-Use
Table Asia Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Flu Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
5.5 Asia Consumption by Region
Table Asia Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Figure Oceania Flu Vaccine Consumption Value (Million USD) and Growth Rate List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Flu Vaccine Revenue Share by Type in 2020 (Million USD)
6.4 Oceania Consumption by End-Use
Table Oceania Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Flu Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
6.5 Oceania Consumption by Region
Table Oceania Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Figure Africa Flu Vaccine Consumption Value (Million USD) and Growth Rate List, 2015-2020
7.3 Africa Production by Type
Table Africa Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Africa Flu Vaccine Revenue Share by Type in 2020 (Million USD)
7.4 Africa Consumption by End-Use
Table Africa Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Flu Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
7.5 Africa Consumption by Region
Table Africa Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Flu Vaccine Production Forecast
Figure Global Flu Vaccine Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
8.2 Global Flu Vaccine Forecast by Type
Table Global Flu Vaccine Revenue by Type, 2020E-2025F (Million USD)
Figure Global Flu Vaccine Revenue Share by Type in 2025 (Million USD)
8.3 Global Flu Vaccine Forecast by End-Use (2020E-2025F)
Table Global Flu Vaccine Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Flu Vaccine Consumption Value Share by End-Use in 2025 (Million USD)
8.4 Global Flu Vaccine Forecast by Region (2020E-2025F)
Table Global Flu Vaccine Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Flu Vaccine Consumption Value Share by Region in 2025 (Million USD)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 AstraZeneca
9.1.1 AstraZeneca Profile
Table AstraZeneca Overview List
9.1.2 AstraZeneca Products & Services
9.1.3 AstraZeneca Company Dynamics & News
9.1.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 CSL Limited
9.2.1 CSL Limited Profile
Table CSL Limited Overview List
9.2.2 CSL Limited Products & Services
9.2.3 CSL Limited Company Dynamics & News
9.2.4 CSL Limited Business Operation Conditions
Table Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 GSK
9.3.1 GSK Profile
Table GSK Overview List
9.3.2 GSK Products & Services
9.3.3 GSK Company Dynamics & News
9.3.4 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Hualun Biologicalsamong
9.4.1 Hualun Biologicalsamong Profile
Table Hualun Biologicalsamong Overview List
9.4.2 Hualun Biologicalsamong Products & Services
9.4.3 Hualun Biologicalsamong Company Dynamics & News
9.4.4 Hualun Biologicalsamong Business Operation Conditions
Table Business Operation of Hualun Biologicalsamong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 ID Biomedical Corporation
9.5.1 ID Biomedical Corporation Profile
Table ID Biomedical Corporation Overview List
9.5.2 ID Biomedical Corporation Products & Services
9.5.3 ID Biomedical Corporation Company Dynamics & News
9.5.4 ID Biomedical Corporation Business Operation Conditions
Table Business Operation of ID Biomedical Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Johnson & Johnson
9.6.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
9.6.2 Johnson & Johnson Products & Services
9.6.3 Johnson & Johnson Company Dynamics & News
9.6.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 MedImmune, LLC
9.7.1 MedImmune, LLC Profile
Table MedImmune, LLC Overview List
9.7.2 MedImmune, LLC Products & Services
9.7.3 MedImmune, LLC Company Dynamics & News
9.7.4 MedImmune, LLC Business Operation Conditions
Table Business Operation of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Mylan
9.8.1 Mylan Profile
Table Mylan Overview List
9.8.2 Mylan Products & Services
9.8.3 Mylan Company Dynamics & News
9.8.4 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Novartis
9.9.1 Novartis Profile
Table Novartis Overview List
9.9.2 Novartis Products & Services
9.9.3 Novartis Company Dynamics & News
9.9.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Pfizer
9.10.1 Pfizer Profile
Table Pfizer Overview List
9.10.2 Pfizer Products & Services
9.10.3 Pfizer Company Dynamics & News
9.10.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Protein Sciences Corporaton
9.11.1 Protein Sciences Corporaton Profile
Table Protein Sciences Corporaton Overview List
9.11.2 Protein Sciences Corporaton Products & Services
9.11.3 Protein Sciences Corporaton Company Dynamics & News
9.11.4 Protein Sciences Corporaton Business Operation Conditions
Table Business Operation of Protein Sciences Corporaton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Sanofi Pasteur
9.12.1 Sanofi Pasteur Profile
Table Sanofi Pasteur Overview List
9.12.2 Sanofi Pasteur Products & Services
9.12.3 Sanofi Pasteur Company Dynamics & News
9.12.4 Sanofi Pasteur Business Operation Conditions
Table Business Operation of Sanofi Pasteur (Sales Revenue, Cost, Gross Margin)
9.13 Serum Institute of India
9.13.1 Serum Institute of India Profile
Table Serum Institute of India Overview List
9.13.2 Serum Institute of India Products & Services
9.13.3 Serum Institute of India Company Dynamics & News
9.13.4 Serum Institute of India Business Operation Conditions
Table Business Operation of Serum Institute of India (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Sinovac Biotech
9.14.1 Sinovac Biotech Profile
Table Sinovac Biotech Overview List
9.14.2 Sinovac Biotech Products & Services
9.14.3 Sinovac Biotech Company Dynamics & News
9.14.4 Sinovac Biotech Business Operation Conditions
Table Business Operation of Sinovac Biotech (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Flu Vaccine Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Flu Vaccine Sales Revenue Share, 2015-2020E, by Companies, in USD
10.2 Regional Market Concentration
Figure Europe Flu Vaccine Market Concentration Ratio in 2020E
Figure America Flu Vaccine Market Concentration Ratio in 2020E
Figure Asia Flu Vaccine Market Concentration Ratio in 2020E
Figure Oceania Flu Vaccine Market Concentration Ratio in 2020E
Figure Africa Flu Vaccine Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Flu Vaccine INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Flu Vaccine INDUSTRY SUMMARY & CONCLUSION
Table Global Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Table Global Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Table Europe Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table America Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
Table America Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Table America Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Table Asia Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Table Oceania Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Flu Vaccine Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Flu Vaccine Revenue by Type, 2015-2020 (Million USD)
Table Africa Flu Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Flu Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Global Flu Vaccine Revenue by Type, 2020E-2025F (Million USD)
Table Global Flu Vaccine Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Flu Vaccine Consumption Value by Region, 2020E-2025F (Million USD)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Limited Overview List
Table Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hualun Biologicalsamong Overview List
Table Business Operation of Hualun Biologicalsamong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ID Biomedical Corporation Overview List
Table Business Operation of ID Biomedical Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune, LLC Overview List
Table Business Operation of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Protein Sciences Corporaton Overview List
Table Business Operation of Protein Sciences Corporaton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Pasteur Overview List
Table Business Operation of Sanofi Pasteur (Sales Revenue, Cost, Gross Margin)
Table Serum Institute of India Overview List
Table Business Operation of Serum Institute of India (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sinovac Biotech Overview List
Table Business Operation of Sinovac Biotech (Sales Revenue, Cost, Gross Margin)
Table Global Flu Vaccine Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Flu Vaccine Sales Revenue Share, 2015-2020E, by Companies, in USD
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
